Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sohyeong Kang
Observed names:
Kang, Sohyeong,
S.H. Kang
Institution:
Zymeworks (Canada)
Observed institutions:
University Health Network,
University of British Columbia,
University of Toronto,
Zymeworks (Canada),
BC Children's Hospital,
Child and Family Research Institute,
BC Children's Hospital Research Institute
show all 7
ORCID:
0000-0002-1352-2508
Observed ORCID:
0000-0002-1352-2508
OpenAlex ID:
A5033883885
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
2023
·
Nina E. Weisser
, Mario Sanches
, et al.
·
Nature Communications
·
209
PDF
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling
2015
·
Theo Klein
, Shan-Yu Fung
, et al.
·
Nature Communications
·
158
PDF
Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2017
·
JongBok Lee
, Mark D. Minden
, et al.
·
Clinical Cancer Research
·
107
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient
2019
·
Jean Quancard
, Theo Klein
, et al.
·
Nature Chemical Biology
·
72
2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells
2016
·
Yu-Hsuan Huang
, Kevin Tsai
, et al.
·
OncoImmunology
·
6
PDF
Abstract 1533: ZW220, a novel NaPi2b-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload
2023
·
Andrea Hernandez Rojas
, Jodi Wong
, et al.
·
Cancer Research
·
3
Efficacy and Safety of Allogeneic Double Negative T Cell As a Cellular Therapy for AML and Its Underlying Mechanism
2015
·
Jong Bok Lee
, Weihsu Claire Chen
, et al.
·
Blood
·
1
Supplementary materials and methods from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2023
·
JongBok Lee
, Mark D. Minden
, et al.
Supplementary Table 1 from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2023
·
JongBok Lee
, Mark D. Minden
, et al.
Supplementary Figures 1-11 from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2023
·
JongBok Lee
, Mark D. Minden
, et al.
Data from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2023
·
JongBok Lee
, Mark D. Minden
, et al.
Data from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
2023
·
JongBok Lee
, Mark D. Minden
, et al.
The role of MALT1 in T cell immunity
2017
·
Kang, Sohyeong
·
cIRcle (University of British Columbia)
SLAM family receptors 2B4 and CD48 are key drivers of CD8 T cell priming by B cells
2016
·
Yu-Hsuan Huang
, Kevin Tsai
, et al.
·
The Journal of Immunology
MALT1-deficient CD4 T cells exhibit decreased IL-2 secretion and impaired Th1 and Th17 differentiation
2016
·
Sohyeong Kang
, Yu-Husan Huang
, et al.
·
The Journal of Immunology
P094 Erythroleukemia might be a possible erythroblastic transformation from myelodysplastic syndrome: molecular cytogenetic study on the clonality of erythroid lineage by immunomagnetic bead and immunophenotyping
2007
·
M.Y. Kim
, S.H. Kang
, et al.
·
Leukemia Research
Show more works
View as search
Works count:
16
Citation count:
556
H-index:
5
I10-index:
4
Year
Topic
Type
